Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5380
[filter] => raw
[cat_ID] => 49
[category_count] => 5380
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
Article and Insights
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5380
[filter] => raw
[cat_ID] => 49
[category_count] => 5380
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
Article and Insights
Drug-Device Combination Products: Where do they fall within the new MDR Regime?
Continuing our series of publications, in this briefing we examine the key changes to the regulat...
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5380
[filter] => raw
[cat_ID] => 49
[category_count] => 5380
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
Article and Insights
Compulsory Licences on the Horizon for Drugs and Equipment?
As concerns grow globally about the availability of certain drugs and equipment in the midst of t...
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5380
[filter] => raw
[cat_ID] => 49
[category_count] => 5380
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
Article and Insights
What Regulatory Challenges are Facing the Life Sciences Sector?
Charleen O’Keeffe discusses some of the regulatory trends and challenges she sees coming down the...
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5380
[filter] => raw
[cat_ID] => 49
[category_count] => 5380
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
Article and Insights
IPHA’s Revised Code of Practice for the Pharmaceutical Industry
Taking effect on 1 March 2021, the IPHA have revised their Code of Practice for the Pharmaceutica...
